Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Net Income (2009 - 2025)

Grifols' (GIFLF) quarterly Net Income came in at $1.4 billion in Q4 2025, up 13.57% on a YoY basis from $1.3 billion in Q4 2024, and up 13.57% quarter-over-quarter from $1.3 billion in Q4 2024.

Analysis

Grifols (GIFLF) Net Income (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Net Income for 16 consecutive years, with $1.4 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Net Income rose 13.57% year-over-year to $1.4 billion; the trailing twelve-month figure through Dec 2025 stood at $2.8 billion (up 147.7% YoY), and the FY2025 full-year result was $824.8 million, up 14.34% from the prior year.
  • Net Income climbed to $1.4 billion in Q4 2025 per GIFLF's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, Net Income topped out at $1.4 billion in Q4 2025 and bottomed at -$214.9 million in Q4 2021.
  • Historically, Net Income has averaged $690.2 million across 4 years, with a median of $763.9 million in 2024.
  • The sharpest annual moves came in 2021 and 2022: Net Income retreated 8.37% in 2021, then soared 217.68% in 2022.
  • Over 4 years, Net Income stood at -$214.9 million in 2021, then jumped by 217.68% to $252.9 million in 2022, then jumped by 404.04% to $1.3 billion in 2024, then climbed by 13.57% to $1.4 billion in 2025.
  • According to Business Quant data, Net Income over the past three periods registered $1.4 billion, $1.3 billion, and $252.9 million for Q4 2025, Q4 2024, and Q4 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn 601.00 Mn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn 164.49 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -290.61 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn 1.45 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.45 Bn
Dec 31, 2024 1.27 Bn
Dec 31, 2022 252.92 Mn
Dec 31, 2021 -214.92 Mn
Dec 31, 2020 -198.33 Mn
Mar 31, 2020 330.09 Mn
Dec 31, 2019 804.11 Mn
Mar 31, 2019 194.84 Mn
Dec 31, 2018 817.44 Mn
Jun 30, 2018 260.55 Mn
Mar 31, 2018 264.14 Mn
Dec 31, 2017 882.31 Mn
Jun 30, 2017 255.10 Mn
Mar 31, 2017 247.88 Mn
Dec 31, 2016 78.21 Mn
Sep 30, 2016 227.94 Mn
Jun 30, 2016 214.39 Mn
Mar 31, 2016 311.60 Mn
Dec 31, 2015 271.10 Mn
Sep 30, 2015 227.51 Mn